Compounds > mitomycin
Page last updated: 2024-08-16

mitomycin and minocycline

mitomycin has been researched along with minocycline in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ara, G; Herman, TS; Holden, SA; Liu, CJ; Teicher, BA1
Fujii, J; Taniguchi, H; Yoshida, S; Yoshimura, K1
Cheng, YW; Kang, JJ; Li, CH; Tzeng, SL1
Chang, PY; Chen, CY; Chen, JC; Chen, WC; Jian, YJ; Jian, YT; Ko, JC; Lin, YW; Syu, JJ; Wang, TJ; Zheng, HY1

Reviews

1 review(s) available for mitomycin and minocycline

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for mitomycin and minocycline

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Minocycline as a modulator of chemotherapy and hyperthermia in vitro and in vivo.
    Cancer letters, 1994, Jul-15, Volume: 82, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Minocycline; Mitomycin; Sarcoma, Experimental; Tumor Cells, Cultured

1994
Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model.
    FEMS immunology and medical microbiology, 1999, Volume: 26, Issue:2

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Colony Count, Microbial; Drug Synergism; Enterotoxins; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Injections, Intraperitoneal; Kanamycin; Male; Mice; Mice, Inbred ICR; Minocycline; Mitomycin; Norfloxacin; Shiga Toxin 2

1999
Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway.
    The Journal of biological chemistry, 2005, Jul-15, Volume: 280, Issue:28

    Topics: Anti-Bacterial Agents; Apoptosis; beta-Galactosidase; Biomarkers; Blotting, Western; Caspase 3; Caspases; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cellular Senescence; Chloramphenicol; Clindamycin; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase 1; Cytochromes c; Cytoplasm; DNA; DNA Damage; DNA, Complementary; Down-Regulation; Doxycycline; Enzyme Activation; Enzyme Inhibitors; G1 Phase; Genes, Reporter; Humans; Membrane Potentials; Membrane Proteins; Microscopy, Fluorescence; Minocycline; Mitochondria; Mitomycin; Oligonucleotides, Antisense; Plasmids; Poly(ADP-ribose) Polymerases; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Protein Biosynthesis; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Ribosomes; RNA; RNA, Messenger; RNA, Small Interfering; Transfection; Tumor Suppressor Protein p53

2005
Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells.
    Biochemical pharmacology, 2015, Oct-01, Volume: 97, Issue:3

    Topics: Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Synergism; Humans; Lung Neoplasms; MAP Kinase Signaling System; Minocycline; Mitomycin; Rad51 Recombinase

2015